1. Introduction
Current imaging methods in breast cancer
Breast cancer is the most common type of cancer and also the leading cause of cancer death among women world-wide [1] . Mammography is one of the cornerstones in the current diagnostic imaging strategy in breast cancer. Investigations of suspicious lesions usually also include ultrasound (US). However, none of the techniques alone have enough sensitivity and specificity for breast cancer detection, although the combination of the two of them improves the diagnostic outcome [2, 3] . Magnetic resonance imaging (MRI) is used for special indications, such as screening of high-risk groups, certain staging procedures and suspicion of multifocal disease to mention some [4, 5] .
Studies have shown that mammographic screening can reduce mortality from breast cancer to about 30% [6] . Currently, mammography is the only approved method for breast cancer screening [7] . Many countries offer populationbased mammography programs for women, the age range differs, but usually include the age group of 50 --69 years, and in some countries down to 40 years and up to 75 years [8] . The radiographic appearance of breast cancer ranges from hardly detectable, minimal signs to obvious signs of cancer. Some radiographic patterns of breast cancer are more easily detected at an early stage, such as spiculated tumors and calcifications, whereas others are difficult to detect such as tumors presenting as non-specific densities and areas with subtle architectural distortion.
The sensitivity of screening mammography with currently used digital mammography (DM) systems is not higher than around 70%, which means that 30% of all cancers are missed [9] [10] [11] [12] . Thus, the sensitivity of mammography for the detection of breast cancer is not optimal. Mammography has limitations to detect cancers especially in dense breasts, that is, breasts with a high proportion of glandular tissue in relation to fat [13, 14] . Younger age is associated with dense breasts as is the use of hormone replacement therapy (HRT) [15, 16] . The dense breast tissue can conceal a tumor on mammography; it may also mimic a tumor even if there is none. Holland et al. [17] reported that 76% of all missed cancers were in dense breasts. The tomographic technique, which reduces or eliminates the detrimental effect of superimposed tissue, can reduce this problem [18] .
Digital mammography
Full-field DM with flat panel detectors has been broadly used in clinical routine for about a decade. Before the introduction of DM, it was debated whether the image quality and in particular the spatial resolution of DM was sufficient for detection of small calcifications [19] . It was concluded, however, that even though the spatial resolution of DM generally is inferior to screen-film mammography, the resolution is sufficient for breast cancer diagnostics [20, 21] . The digital technique provided a number of desirable properties like increased contrast resolution compared with screenfilm mammography, fast transfer and simplified storage of images in PACS (picture archiving and communication systems) and image processing [22] .
Breast tomosynthesis
The term 'tomosynthesis' was defined by Grant [23] in 1972, but it was not until the late 90s that technical developments made the technique practically possible for investigating patients. These developments included flat panel detectors with high readout speed and dose efficiency (high DQE [24] ), and computers with high computational power, allowing reasonable image reconstruction times [25] [26] [27] . Originally, breast tomosynthesis (BT) units were developed at research institutions in cooperation with manufacturers of mammography systems [28, 29] and somewhat later by manufacturers with the intention to develop commercial systems [30] . Tomosynthesis differs from conventional geometric tomography in that it allows visualization of any plane in the imaged object, whereas with tomography only the focal plane, as decided by the pivot point of the tube movement, is visualized [26] . A new exposure is thus required if another plane in the patient is to be examined. BT seems to be a particularly interesting application of tomosynthesis as BT is a straightforward development of DM (similar equipment, patient examination technique and visual impression of the images), and currently there is no other three-dimensional (3D) X-ray technique available for breast examinations.
In BT [28, [31] [32] [33] [34] , a number of low-dose images (usually 11 --25) of the compressed breast are acquired from different angles, as the X-ray tube moves along a limited arc, typically between 15 and 50 ( Figure 1 ) [35] . The angular spacing as well as the total dose is often homogenously distributed over this arc. The detector is generally stationary (exception: slot-scanning detector). The tube movement is either continuous or a step-and-shoot movement where the tube stops moving at the time of each exposure [36] . Continuous movement causes a slight movement unsharpness (focal spot blur) which often can be neglected provided that the X-ray pulses are short or that the tube movement is slow. With step-and-shoot movement, the tube must come to a complete stop to avoid motion blur from tube vibration. This causes a slow image acquisition with possible image blur from patient movement as a consequence [37] . In a simulation study, Shaheen et al. [38] showed that the step-andshoot is beneficial with respect to MTF (modulation transfer function), not taking into account the extended image acquisition time with this method, which may result in patient movement. The so-called projection images that are acquired during the tube movement are reconstructed to a 3D volume with mathematical algorithms, similar to computed tomography (CT). Filtered back-projection (FBP) has frequently been used because of its speed, but several research groups are developing and evaluating this and other types of reconstruction algorithms, for example maximum likelihood expectation maximization (MLEM) and simultaneous algebraic reconstruction technique (SART) [39] [40] [41] [42] [43] . No general conclusion on which algorithm is the better one has yet been reached. From the reconstructed 3D volume, individual thin slices can be studied, either as a movie (in a cine-loop) or stepped through manually one-by-one [44] . Each slice image contains much less of the This box summarizes key points contained in the article.
Digital mammography and tomosynthesis for breast cancer diagnosis superimposed normal tissue than the conventional twodimensional (2D) image. Detection of subtle details, like small tumors with low contrast, is therefore improved (Figure 2 ). For diagnostic purposes, a slice separation of 1 mm has commonly been used, but to reduce radiologist's reading time, which is directly connected to the number of slice images, projects are underway to generate thicker image slabs [45] and to study the effect of thicker slices on the detection of breast lesions.
Technical aspects of BT image volume acquisition
In CT the object is completely sampled as the X-ray tube and detector arc rotates around the object [46] . Contrary to CT where the object is imaged while the X-ray tube and the detector makes a complete revolution around it, the incomplete sampling in tomosynthesis due to the limited angular range, gives rise to loss of information in the depth direction [40] . This is expressed in the tomosynthesis images as out-of-plane artifacts [47] . By increasing the angular range, the magnitude of the out-of-plane artifacts, characterized by the artifact spread function (ASF) [39] , will be reduced [48] [49] [50] . On the other hand, a larger angular range could result in increased in-plane artifacts [51] , as well as a longer image acquisition time. Figure 3 shows a millimetre-sized calcification seen in four different slice images, in the focus plane (a) and outside (b --d). The angular range was 50 , 25 projection images were acquired and FBP was used for the reconstruction. Since the calcification is a high-contrast object it generates an artifact of rather high magnitude, and thus is clearly visible even outside the focus plane. The artifact manifests as a line which is smeared out in the same direction as the scanning direction of the X-ray tube. The figure also shows an in-plane artifact (black area above and below the calcification) that manifests in the scanning direction. This artifact actually improves the visibility of the calcification. The magnitude of in-plane artifacts was studied by Svahn et al. [52] , who found that the magnitude of the artifacts was directly proportional to the contrast and the size of the artifact-generating object.
The radiation dose from one tomosynthesis image acquisition is generally the same as the total dose from two projections in mammography (craniocaudal, CC + mediolateral oblique, MLO) [53] [54] [55] . Dose levels between 1.6 mGy [53] and 4 mGy [54] have been reported. The total tube loading (mAs value) is often divided equally among the projection images [55] , but recently the effect of spending a larger fraction of the total dose on the center projection in order to increase detection of microcalcifications have been investigated [56] [57] [58] . Spangler et al. [59] did not find any difference in area under the receiver operating characteristic (ROC) curve [60] for BI-RADS (breast imaging reporting and data system) scores of calcifications for DM and BT, although they found a higher sensitivity for calcification detection. Experiments have also been performed in which the angular spacing is varied [61] . As the total dose for tomosynthesis is closely linked to the number of projections and the angular range, the optimum value of these parameters depend on each other. Sechopoulos and Ghetti [50] simulated 63 different combinations of angular range (from 8 to 60 ) and number of projections (from 5 to 61), based on 50 unique breast tissue volumes, and found that the depth resolution increased with angular range. Since they had set an upper limit to the average glandular dose they found an optimal number of projections, due to the increase in noise in the projection images which was seen in the reconstructed images. Chawla et al. [62] based their study on mastectomy samples which they imaged with tomosynthesis and simulated lesions were added to the tomosynthesis volumes. At a dose level similar to single-view mammography, they found that the optimum number of projection images was 15 --17 at an angular range of 45 . The optimum angular spacing in both the studies conducted by Sechopoulos and Ghetti [50] and Chawla et al. [62] was around 3
. Timberg et al. [63] investigated the dose level required for detection of different types of breast lesions and found that detection of lowcontrast lesions with diffuse borders required twice the dose of a single DM image, whereas spiculated high-contrast lesions or lesions with well-defined borders could be detected at lower dose levels. The beam quality is generally the same as the corresponding 2D examination [53] , and no studies optimizing this parameter have been published. Reproduced with permission from [34] . selected on the basis of DM. Poplack et al. [54] reported that the image quality, including lesion conspicuity and feature analysis, of BT was equivalent or superior to DM in 89% of the 98 cases examined. In a study by Andersson et al. [53] , 40 cancers which were subtle on DM were in addition imaged with BT, and evaluated with BI-RADS [64] by two experienced breast radiologists in consensus. The study showed that the BI-RADS scores with BT were significantly higher than with DM, indicating that lesions that were classified as benign with DM were more likely to be upgraded to a higher level of malignancy suspicion with BT and with a better correspondence with the true malignancy grade at pathologic--anatomic diagnosis. The study by Andersson et al., in contrast to other studies, only involved cases that proved to be difficult on DM and therefore emphasized those differences, which probably led to the significant difference between BT and DM. In the study by Good et al. [65] , 30 cases were evaluated by nine observers, both subjectively and under the free-response ROC (FROC) paradigm [66] . Although the observer performance test did not show a significant difference, which the authors attribute to the low number of cases, the subjective rating showed that 67% of the cases deemed BT as 'somewhat better' or 'significantly better' than DM, and 31% deemed as comparable.
If to be used in screening, BT's ability to reduce false positive examinations is of great interest. Gur et al. [67] compared DM with BT alone and with a combination of DM and BT. They included 125 selected examinations, 35 with verified cancers and 90 without cancers, and the images were interpreted by eight experienced radiologists. They found that the combination of DM and BT led to a 30% reduced recall rate for cancer-free examinations that would have led to recall if DM would have been used alone. The authors did not find any substantial improvements for sensitivity for BT alone or in combination with DM, compared with DM. There is no clear statement about the level of recall rate in that study and the results may be more applicable to the US compared with European circumstances, where recall rates with DM are less than 5% [7, 9] . In a recently published document by the Food and Drug Administration, two other observer performance experiments comparing DM with a combination of DM and BT were carefully analyzed [68] . In the first study comprising 312 examinations (48 cancers), a two-view BT examination was used in combination with the DM images, whereas in the second study (including 310 examinations, 51 cancers) the DM images were accompanied by a BT examination in the MLO projection. The results of the two studies showed a significant reduction in recall rate and improved clinical performance (expressed as the area under the ROC curve, AUC) for the DM and BT combination compared with DM alone. The combination including two-view BT was better than the BT MLO combination. There was a significant improvement in the AUC for non-calcified tumors for the DM and BT combination (for both studies) compared with DM alone. For calcified tumors the difference was not significant. These results are in agreement with the study by Gur et al. [67] . Again, it seems like the recall rates of these studies are substantially higher than what is used in Europe. Teertstra et al. [69] imaged 513 cases suspicious from screening, containing 112 cancers, with DM and BT. By using BI-RADS scores 4 and 5 as positive, they found that BT had a higher sensitivity than DM (80 and 73%, respectively) at a similar specificity (97 and 96%, respectively). Gennaro et al. [55] recruited 200 patients who had at least one lesion (malignant or benign) discovered by mammography and/or US. The patients underwent BT in the MLO projection, and all images (DM and BT) were evaluated by six experienced breast radiologists in an ROC study. Although lesion conspicuity was better with BT than DM, the ROC analysis did not show a significant difference in diagnostic accuracy between BT and DM. Again, a larger patient population would probably be needed to show such differences. Svahn et al. [70] imaged 50 breasts (25 abnormal and 25 normal/benign) with two-view DM and BT in the MLO projection. Three different evaluation schemes were used, based on DM and BT: two-view DM, BT and BT combined with the CC projection of this breast. These image combinations were viewed and rated by five expert breast radiologists in a FROC study. The combined modality, DM in the CC projection and BT in the MLO projection was significantly better than two-view DM. Comparison of the other viewing strategies (combined vs. BT or BT vs. DM) yielded no significant differences. In a computer simulation study, Gong et al. [71] generated images with added lesions from a DM system and a BT system based on a model of a breast. The images were evaluated by five observers in an ROC study, and the authors found a Digital mammography and tomosynthesis for breast cancer diagnosis significantly higher diagnostic performance (expressed as the area under the ROC curve) for BT than for DM. In a recently published experiment with photon-counting BT, Svane et al. presented 144 cases (96 malignant) viewed by two radiologists and assessed both individually and comparing the two techniques. In 56% of the cases the radiologists rated the diagnostic quality of the lesion details significantly higher in the tomosynthesis images than in the conventional images (and in 91% equal or higher). This included the calcifications which were rated as having better quality in 41% of the cases (Figure 4 ) [72] .
To evaluate BT as a screening modality, large population-based screening trials are needed. Currently two such studies are carried out [73] . ' The Malm€ o Breast Tomosynthesis Screening Trial (MBTST)' includes 15,000 women aged 40 --74 years in Malm€ o, Sweden, and in Norway the 'Digital Breast Tomosynthesis in the Oslo Mammography Screening Program' study includes 25,000 women aged 50 --69 years in the population-based screening programs.
Compression force and image quality
There are a number of studies that attempted to optimize different parameters of the tomosynthesis image acquisition procedure or investigated specific image quality parameters, for example, detection of microcalcifications under different conditions, or examined potential advantages with BT compared with DM. More than a decade ago it was foreseen that tomosynthesis could be performed with less compression force than what is used for mammography, and that reduced force would even be beneficial because of the depth resolution of tomosynthesis [22, 25] . Saunders et al. [74] investigated the effect of compression force on lesion conspicuity for masses and microcalcifications in a Monte Carlo study and found that it was possible to reduce compression by 12.5% at constant average glandular dose without decreasing lesion conspicuity. In a study by F€ ornvik et al. [75] , 45 women were investigated with standard compression force at BT (i.e., the force that is used at an ordinary mammography examination) and at half of that force. The quality of the images was evaluated in a visual grading analysis [76, 77] study by three experienced Reproduced with permission from [34] . radiologists and the results showed no significant difference in image quality. Timberg et al. [78] studied contrast threshold for detection of simulated structures inserted in normal breast backgrounds with DM and BT and found that detection of 1 mm and larger lesions was significantly better with BT, but for the 0.2 mm lesions, DM outperformed BT.
Breast cancer size is important in preoperative planning and as a prognostic indicator. F€ ornvik et al. [79] investigated if breast cancer size could be more accurately assessed, due to improved visualization of tumor margins with BT than with DM or US. BT, DM and US sizes of 73 breast cancers were measured independently by an experienced radiologist without knowledge of the pathology results, which were used as reference. BT and US size correlated well with pathology, and significantly better than DM size. Tumor staging was, therefore, significantly more accurate with BT than with DM.
Reading times in BT
The examination time for BT is roughly the same as for the corresponding 2D examination. However, the image reading time (or radiologist time) is one of the major concerns if tomosynthesis should gain a general acceptance for clinical routine use, especially in breast screening where the patient throughput is extremely high (around 1 min reading time per patient). Although there are a few screening studies underway, there are no studies yet that have investigated image reading time under this condition. It is known that the reading time of BT is longer than for DM, reported to be up to 70% longer [67] or even twice as long or more [80] . It is often the PACS system that limits the reading time, since the retrieving of the tomosynthesis image volume is generally much more time consuming than for 2D as the amount of data in tomosynthesis examination are much larger. The reading time could be decreased by optimized viewing tools or viewing strategies (e.g., Lång et al. [81] ), quicker PACS systems, etc. Thicker slice images (i.e., fewer slices per breast) could also be a successful strategy for reducing the image reading time. Even though the reading time is longer for tomosynthesis than for the corresponding 2D examination, it may be possible to gain radiologist time by the increased diagnostic information of tomosynthesis which hopefully will decrease the number of false positives (thus reducing recall rate), and shorten the reading time for difficult negative cases.
Conclusion
BT in several studies has shown potential to considerably improve the diagnostic accuracy in early detection of breast cancer. It has applications both for clinical breast cancer imaging as well as for screening purposes. The true potential of BT in both fields remains to be further evaluated in clinical trials. We will not have the answer to the question whether BT can replace DM in mammography screening until a couple of years from now, at the earliest. 
Expert opinion
The commercial introduction of BT has been relatively slow. Outside the USA, BT has been available for approximately 2 years, but only recently the first BT system was approved for sale in the USA. There seems to be a big interest in the radiological community for the technique. The reason for this is obviously that BT has shown potential for increased diagnostic accuracy displayed on several scientific meetings. Furthermore, many radiology departments that have been digital for almost a decade are about to exchange their direct-digital DM units, and since the handling of a BT unit is similar to a DM unit, the implementation of BT is rather straightforward. For a relatively small added cost they can buy the tomosynthesis capability to get access to the new imaging modality.
When evaluating a new diagnostic technique, the most efficient way of getting an indication of its performance is to try it on smaller, enriched populations. If it does not show any advantages compared with a gold standard technique in that setting, given equal conditions, it is unlikely that it would work in a non-selected population. Many of the clinical studies published so far are in this initial stage and have shown promising results. In a next step it would be desirable to see larger, unbiased studies confirming BT's potential.
Based on our experiences with BT and the results from other research groups, it is the authors' belief that BT will be a valuable modality in early detection of breast cancer in a screening situation at least in women with dense breasts. There are several examples published where lesions imaged with BT is considerably better visualized than with DM. It might seem surprising that the studies presented so far do not present stronger evidence for better performance corresponding to what these examples suggest. The lack of significantly different results in some of the studies presented in this paper could probably be explained by the relatively low number of patients involved in those studies. In many of the studies the study design already favors DM because the cases included were based on what was seen at DM. It is likely that difference in lesion visualization between BT and DM is small and only manifests in a few cases per thousand women. Larger studies involving thousands of women will give valuable information about the potential benefits of BT compared with DM. The results from the ongoing screening trials will form the basis for the potential use of BT in screening. In general, breast cancer screening has been considered cost-effective [82] . The cost-effectiveness of BT compared with DM in screening for breast cancer has not been evaluated and is also yet to be proved.
Besides the fact that larger studies are missing, there is little knowledge in how BT will be used in the clinical routine. Which projections should be used, for example, BT in MLO alone, BT in MLO and CC or BT combined with DM? The latter might be useful in some clinical cases, but in our opinion it has to be carefully investigated before implementing combinations of DM and two-view BT in larger populations such as in screening, considering the radiation dose. What would be the optimum image reading conditions of BT images? Should the images be displayed in a cineloop or manually scrolled? What slice thickness should be used? There are many research projects that are exploring the more theoretical parts of BT, like acquisition parameters and reconstruction algorithms but few that explore the clinical use of tomosynthesis. For personal use only.
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